Clinical, biological, and prognostic implications of SF3B1 co-occurrence mutations in very low/low- and intermediate-risk MDS patients

Janusz, K; Izquierdo, MM; Cadenas, FL; Ramos, F; Sanchez, JMH; Lumbreras, E; Robledo, C; del Real, JS; Caballero, JC; Collado, R; Bernal, T; Pedro, C; Insunza, A; de Paz, R; Xicoy, B; Salido, E; Garcia, JS; Minguez, SS; Garcia, CM; Munoz, AMS; Barba, MS; Rivas, JMH; Abaigar, M; Campelo, MD